CStone and Kimia Therapeutics Enter Clinical Development Collaboration to Advance a Novel Drug Candidate Targeting Repair Pathways Critical for Solid Tumor Survival

The Quick Take
SUZHOU, China, Nov. 3, 2026 /PRNewswire/ -- CStone Pharmaceuticals ("CStone," HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of therapies for oncology, immunology, inflammation, and other key disease areas, today announced that it has...
Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to PR Newswire M&A.
Related
Business
/C O R R E C C I O N -- Compal Electronics, Inc./
En el comunicado de prensa titulado "Verda y Compal amplían su colaboración en infraestructura global de IA en GTC Berlín 2026", publicado el 22 de octubre de…
Business
MEIYUME PRÄSENTIERT: BEACON AUF DER COSMOPACK ASIA 2026
Den nächsten Schritt in der Schönheitswelt meistern HONGKONG, 4. November 2026 /PRNewswire/ -- Meiyume kehrt mit BEACON zur Cosmopack Asia am Stand 3-C01…
Business
MEIYUME PRESENTS: BEACON AT COSMOPACK ASIA 2026
Navigating What's Next in Beauty HONG KONG, Nov. 3, 2026 /PRNewswire/ -- Meiyume returns to Cosmopack Asia at Booth 3-C01 with BEACON—an immersive beauty…
Business
1Finity, a Fujitsu Company, Announces Availability of Full-Stack Enterprise AI-Native vRAN Solution
KAWASAKI, Japan--(BUSINESS WIRE)-- #AI--1Finity unveils full-stack AI-Native vRAN solution built on the NVIDIA AI Aerial platform, enabling Mobile Network…
